| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/16/2013 | US8420780 Mutated netrin 4, fragments thereof and uses thereof as drugs |
| 04/16/2013 | US8420759 Polymers of isoprene from renewable resources |
| 04/16/2013 | US8420603 SPARC and methods of use thereof |
| 04/16/2013 | US8420406 Method for analysing metabolites |
| 04/16/2013 | US8420403 Method for evaluating caking property of sodium hydrogencarbonate crystal particles |
| 04/16/2013 | US8420402 Compounds related to assays |
| 04/16/2013 | US8420401 Glucose tolerance test device |
| 04/16/2013 | US8420400 System and method for authenticating tablets |
| 04/16/2013 | US8420399 Analytical method of hemoglobin |
| 04/16/2013 | US8420398 Estrous cycle monitoring by color response |
| 04/16/2013 | US8420348 Antibodies for the detection of integrin complexes in FFPE material |
| 04/16/2013 | US8420340 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 04/16/2013 | US8420339 Methods for predicting pregnancy outcome in a subject by hCG assay |
| 04/16/2013 | US8420338 Serum MG53 as a diagnostic marker for tissue injury |
| 04/16/2013 | US8420337 Lipoprotein-associated markers for cardiovascular disease |
| 04/16/2013 | US8420336 Method of bioassaying yokukansan |
| 04/16/2013 | US8420335 Inhibition of GASC1 |
| 04/16/2013 | US8420334 Method for detecting invasive microvesicles derived from tumor cells |
| 04/16/2013 | US8420333 G-protein coupled receptor-associated sorting protein 1 as a cancer biomarker |
| 04/16/2013 | US8420332 Tumor endothelial marker 5-α molecules and uses thereof |
| 04/16/2013 | US8420331 Type IV collagen-like immunoreactive peptide |
| 04/16/2013 | US8420330 Diagnosis and treatment of cardiac troponin 1 (cTn1) autoantibody-mediated heart disease |
| 04/16/2013 | US8420329 Methods for diagnosing or treating prostate cancer |
| 04/16/2013 | US8420328 Reusable nanowire field effect transistor system for detecting biomolecular interactions |
| 04/16/2013 | US8420327 Analyte sensors, methods for preparing and using such sensors, and methods of detecting analyte activity |
| 04/16/2013 | US8420326 Method of evaluating performance of activation gas deactivating antigenic substance and apparatus for generating processed antigenic substance used as evaluation sample of the evaluating method |
| 04/16/2013 | US8420321 Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-Ile347 polymorphism |
| 04/16/2013 | US8420314 Using E6 viral transcript expression as diagnostic indicator in detection and classification of cervical cancers |
| 04/16/2013 | US8420310 Method for detection of idiopathic interstitial pneumonia |
| 04/16/2013 | US8420306 Cell division marker |
| 04/16/2013 | US8420181 Method of producing microfluidic devices based on a polymer |
| 04/16/2013 | US8419961 Oil/gas separation membrane, its use in gas sensor and process for producing the same |
| 04/16/2013 | US8419912 Water quality analyzer |
| 04/16/2013 | US8418523 Calibration and accuracy check system for a breath tester |
| 04/16/2013 | CA2739530C Method of evaluating foam-holding property of fermented malt drink and marker for evaluating foam-holding |
| 04/16/2013 | CA2666662C Methods to utilize invertebrate chemosensory proteins for industrial and commercial uses |
| 04/16/2013 | CA2628315C Compositions and methods for the detection of trypanosoma cruzi infection |
| 04/16/2013 | CA2568162C Binding molecules capable of neutralizing rabies virus and uses thereof |
| 04/16/2013 | CA2562001C Methods of assessing characteristics of fibrous substrates and treating fibrous substrates |
| 04/16/2013 | CA2558033C Hybrid nanoparticles including an ln2o3 core and having bioligands, and method for preparing same |
| 04/16/2013 | CA2554060C Electrochemical biosensor |
| 04/16/2013 | CA2527722C Biodegradable poly(beta-amino esters) and uses thereof |
| 04/16/2013 | CA2517687C Electrochemical-based sensor with a redox polymer and redox enzyme entrapped by a dialysis membrane |
| 04/16/2013 | CA2498614C Analyzing nerve cell damage |
| 04/16/2013 | CA2476846C Method for detection of leptin receptor ligands |
| 04/16/2013 | CA2465973C Posh nucleic acids, polypeptides and related methods |
| 04/16/2013 | CA2453366C Methods, apparatus, and computer programs for verifying the integrity of a probe |
| 04/16/2013 | CA2436746C Charge tags and the separation of nucleic acid molecules |
| 04/16/2013 | CA2412504C Antigenic polypeptides |
| 04/16/2013 | CA2412052C Method for modifying plant morphology, biochemistry and physiology |
| 04/16/2013 | CA2410894C Flow cytometry-based hematology system |
| 04/16/2013 | CA2361246C Identification of specific differentially expressed antigens |
| 04/16/2013 | CA2271783C Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 04/15/2013 | DE202012012084U1 Testkit (Kombi-Schnelltest) zum synchronen Nachweis von Biomarkern im Stuhl zur Erkennung pathologischer Veränderungen im Gastrointestinaltrakt, insbesondere im Darm Test kits (Combined Rapid Test) for synchronous detection of biomarkers in the chair for the detection of pathological changes in the gastrointestinal tract, especially in the gut |
| 04/13/2013 | CA2791762A1 Process and test cell for a hardening agent |
| 04/11/2013 | WO2013052947A1 Junctional retroviral peptides and their use in identifying novel targets for antiretroviral drugs |
| 04/11/2013 | WO2013052946A2 Genetically encoded biosensors |
| 04/11/2013 | WO2013052933A2 Myosin binding protein-c for use in methods relating to diastolic heart failure |
| 04/11/2013 | WO2013052926A2 Methods and compositions for single chain variable region enox2 antibodies for cancer detection and diagnosis |
| 04/11/2013 | WO2013052915A2 Method for detecting replication or colonization of a biological therapeutic |
| 04/11/2013 | WO2013052888A1 Hsf 1 as a marker in tumor prognosis and treatment |
| 04/11/2013 | WO2013052796A1 Classification scheme of sized bridging materials for superior drill-in fluid design |
| 04/11/2013 | WO2013052747A2 Methods and systems for configuring sensor acquisition based on pressure steps |
| 04/11/2013 | WO2013052745A1 Predicting tumor response to anti-erbb3 antibodies |
| 04/11/2013 | WO2013052686A1 Srm/mrm assay for the receptor tyrosine-protein kinase erbb-4 protein (her4) |
| 04/11/2013 | WO2013052631A1 Semaphorin 7a induced lung fibrogenesis occurs in a cd4-dependent, macrophage dependent manner |
| 04/11/2013 | WO2013052612A2 Method and system to monitor the state and function of the cervix and effects of treatments for the cervix |
| 04/11/2013 | WO2013052582A2 Generation of antibodies to an epitope of interest that contains a phosphomimetic amino acid |
| 04/11/2013 | WO2013052484A1 Dye conjugated peptides for fluorescent imaging |
| 04/11/2013 | WO2013052480A1 Marker-based prognostic risk score in colon cancer |
| 04/11/2013 | WO2013052341A1 Array domains having rotated patterns |
| 04/11/2013 | WO2013052168A2 Detection aib1-delta 4 protein |
| 04/11/2013 | WO2013052092A1 Method of activation of noble metal for measurement of glucose and associated biosensor electrode |
| 04/11/2013 | WO2013052090A1 Improved and automated method for quality control and quality assurance of sized bridging material |
| 04/11/2013 | WO2013052085A1 Improved and automated method for quality control and quality assurance of sized bridging material |
| 04/11/2013 | WO2013052062A1 Mercury gas sensing using terahertz time-domain spectroscopy |
| 04/11/2013 | WO2013051992A1 A device, a system and a method for alcohol measurement |
| 04/11/2013 | WO2013051890A2 Method for manufacturing multiple-diagnosis membrane sensor by using screen printing |
| 04/11/2013 | WO2013051889A2 Membrane sensor enabled with sequential change of reaction condition with single sample injection |
| 04/11/2013 | WO2013051846A2 Complex membrane for a western blot including pvdf nanofibers, and method for manufacturing same |
| 04/11/2013 | WO2013051769A1 Multi-fluorescent substance including novel coumarin derivative, and led light source-based microfluorescent quantitative biosensor for diagnosis using same |
| 04/11/2013 | WO2013051710A1 Diagnostic marker for gastrointestinal cancer, and testing method for gastrointestinal cancer |
| 04/11/2013 | WO2013051704A1 Glucose dehydrogenase |
| 04/11/2013 | WO2013051651A1 Method for analyzing biomolecules and biomolecule analyzer |
| 04/11/2013 | WO2013051606A1 Monoclonal antibody capable of specifically recognizing asparagine synthase |
| 04/11/2013 | WO2013050998A1 Cd247 as a biomarker for assessing the effect of chemotherapeutic and biological drugs |
| 04/11/2013 | WO2013050921A1 Hollow polymer microspheres as three-dimensional cell culture matrix |
| 04/11/2013 | WO2013050731A1 Prognostic method for diabetes |
| 04/11/2013 | WO2013050705A1 Method for identifying cancer that is aggressive and/or likely to develop metastases |
| 04/11/2013 | WO2013050701A1 Assembly for determining the presence or absence of an analyte in a blood sample and analysis unit comprising such an assembly |
| 04/11/2013 | WO2013050603A1 Method for the direct detection and/or quantification of at least one compound with a molecular weight of at least 200 |
| 04/11/2013 | WO2013050598A1 Method for detecting bacteria |
| 04/11/2013 | WO2013050573A1 C-mip : a biomarker of lupus nephritis |
| 04/11/2013 | WO2013050572A1 Resistivity meter capable of evaluating the resistivity of a floor using galvanic and electrostatic electric measurement methods |
| 04/11/2013 | WO2013050567A1 Phosphospecific antibodies recognising tau |
| 04/11/2013 | WO2013050554A1 Carbohydrate functionalised surfaces |
| 04/11/2013 | WO2013050544A1 Method of easily identifying lubricating oils, identification kit and lubricating oils that can be easily identified |
| 04/11/2013 | WO2013050472A1 Diagnostic test comprising inositol for the assessment of the fertilising ability of human spermatozoa |
| 04/11/2013 | WO2013050457A1 Characterization of cho-mif gene and protein, and use thereof |
| 04/11/2013 | WO2013050453A1 Oxmif as a diagnostic marker |